Abstract:Nina Hein, 1 Conner Callaway, 2 Devin Ford, 2 John C Carlson 1 1 Ochsner Health System, Department of Allergy and Clinical Immunology, New Orleans, LA, USA; 2 Tulane University, School of Medicine, New Orleans, LA, USA Correspondence: John C Carlson, Department of Pediatrics, Ochsner Health System, 1315 Jefferson Hwy, New Orleans, LA, 20121, USA, Tel +1-504-842-3900, Fax +1-504-842-5848, Email For patients that have experienced a systemic allergic reaction induced by Hymenoptera venom, venom immunotherapy (VIT) dramatically reduces the risk of subsequent reactions. 1 Similarly, whole body extracts (WBE) are used in immunotherapy for Solenopsis (fire ant) species allergy with improvements in prognosis comparable to VIT. 2 Among the barriers to diagnosis and management of insect hypersensitivity is the need for allergy testing for the selection of immunotherapy extracts prior to immunotherapy. 3 Testing is generally performed after a theoretical 6-week refractory period following an anaphylactic event, by an allergist that performs and interprets venom allergy testing varies. Testing options include skin and serum tests, with current guidelines recommending skin testing followed by serum testing when results are negative. At some centers, the order of testing has been reversed for reasons that include time constraints and costs that limit skin testing along with increased sensitivity of serum testing. Allergists rely on venom allergy testing to help select the appropriate extracts for use in desensitization. Allergists may be hesitant to narrow the scope of testing based on patient history. This hesitance stems from a single study, which questioned the reliability of patient-reported information concerning insect taxonomy. It is worth noting that this study primarily considered patient knowledge of insects rather than the expertise of physicians in interpreting patient history. 4 Current guidelines do recognize the potential of history-based approaches, particularly when the identity of the offending insect is unequivocal. 5 For instance, the presence of a sterile pustule following a sting is widely regarded as pathognomonic for fire ant stings. In cases where expert identification of the insect is feasible, such as when a specimen is brought in by the patient, this further supports restricting the scope of venom allergy testing. Allergists that infrequently perform venom immunotherapy may be unaware of the relative usefulness of history elements in selecting venom extracts for testing and desensitization. Our study was conducted to determine how often elements of the history could be used to restrict the number of taxa for which patients were desensitized in a referral center for patients with venom-induced anaphylaxis. After approval by the Ochsner health system IRB with a waiver of informed consent due to minimal risk, we conducted a retrospective chart review of 52 patients who initiated VIT with an ultrarush induction protocol at our New Orleans center from 2016 to 2022. Patients were identified using CPT codes (9513X, 9514X, or 95170) indicating immunotherapy with Hymenoptera venom extracts or fire ant WBE. All patients who underwent ultrarush were included, with no patients excluded. The time elapsed between the initial anaphylactic reaction and the initiation of immunotherapy was determined. For adult patients with a history of reaction in childhood (without specified age), the date the patient turned 18 years old was assigned. When only a year was documented in the patient's chart, the last date of the year was used. Patient history was examined for elements used for extract selection. Elements used for implicating are listed in Table 1. When history implicated an insect, testing results were analyzed to determine concordance between history, testing results, and final extract used for desensitization. Table 1 Elements Used to Implicate the Genus of Insect Causing Anaphylaxis for 52 Patients Undergoing Rush Immunotherapy in New Orleans, Louisiana All patients (N = 52) who underwent the ultrarush procedure were included, with no patients excluded. Demographic data based on self-reported sex revealed that 58% of patients were female (N = 30), while 42% were male (N = 22). The study comprised 29% pediatric patients (18 years old or younger at the time of the ultrarush procedure) and 71% adult patients. Regarding race, 75% of patients identified as White (N = 39), 13% as Black (N = 7), 4% as Native American (N = 2), 2% as Asian (N = 1), 2% as Mixed (N = 1), 2% as Other (N = 1), and 2% did not report their race (N = 1). Our results showed that the average delay between an anaphylactic event and venom immunotherapy initiation was 1,018 days (range = 24 days to 37.6 years; SD = 2,831 days), but this decr -Abstract Truncated-

Using test dose challenges to restore essential therapy in patients with idiopathic anaphylaxis and pharmacophobia: report of a patient with idiopathic anaphylaxis and statin phobia

Safe Medication Use Based on Knowledge of Information about Contraindications Concerning Cross Allergy and Comprehensive Clinical Intervention

Tryptase in drug-induced anaphylaxis: the need for acute and baseline values

Lipid transfer protein syndrome: How to save a life through careful education

Single-Dose Oral Tolerance Test with Alternative Compounds for the Management of Adverse Reactions to Drugs

Identifying patients at risk of anaphylaxis

Navigating Aspirin Hypersensitivity in Patients Undergoing Percutaneous Coronary Intervention

Deliberate hymenoptera sting challenge as a diagnostic tool in highly selected venom-allergic patients

Promoting penicillin allergy de‐labeling for children attending a hematology clinic

The patient who reports a drug allergy

Patient Perceptions of Penicillin Allergy Testing in a Public Health System

The Role of the Basophil Activation Test in the Diagnosis of Drug-Induced Anaphylaxis

Case report of an unusual allergic reaction to a routine skin prick test performed in an outpatient clinic: Diagnosis, management, and knowledge gaps

Clinical features and potential markers of disease in idiopathic non-histaminergic angioedema, a real-life study

Patient History Is Often Reliable in Cases of Venom-Induced Anaphylaxis: A Retrospective Observational Study

Anaphylaxis To Aeroallergen Immunotherapy: An Early Symptom Of Systemic Mastocytosis

Rising to the Challenge: An ID Provider–Led Initiative to Address Penicillin Allergy Labels at a Large Veterans Affairs Medical Center

Randomized Multicenter Trial for the Validation of an Easy to Administer Algorithm to Define Penicillin Allergy Status in Sexually Transmitted Infection Clinic Outpatients

Exercise-induced anaphylaxis unrelated to food ingestion and with hyperleukotrieneuria during challenge testing

Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy

Shelling the myth: allergies to Iodine containing substances and risk of reaction to Iodinated contrast media